EUVIMEDEUVIMED entdecken
Crossref

Single Cell Inference of Cancer Drug Response Using Pathway‐Based Transformer Network

Yinghao Yao iD, Yuandong Xu, Yaru Zhang, Yuanyuan Gui, Qingshi Bai, Zhengbiao Zhu, Hui Peng, Yijun Zhou, Zhen Ji Chen, Jie Sun, Jianzhong Su iD

Small Methods · 2025

DOI: 10.1002/smtd.202400991 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Small Methods, 2025. Verfasst von Yinghao Yao und 10 weiteren Autor:innen. Beteiligte Einrichtung: Oujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325…. Hauptthemen laut MEDLINE: Single-Cell Analysis, Antineoplastic Agents, Neoplasms, Breast Neoplasms. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 60 Literaturangaben. Gefördert von: National Key Research and Development Program of China, National Natural Science Foundation of China, Zhejiang Provincial Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Accurate prediction of cancer drug responses is crucial for personalized therapy. Single‐cell RNA sequencing (scRNA‐seq) captures cellular heterogeneity and rare resistant populations, offering valuable insights into treatment responses. However, the distinct distributions of bulk RNA‐seq and scRNA‐seq data hinder the transfer of drug response knowledge from large‐scale cell line datasets. To address this, single‐cell Pathway Drug Sensitivity (scPDS) model is developed, a Transformer‐based deep learning method that predicts drug sensitivities from scRNA‐seq data through pathway activation transformation. By integrating bulk RNA‐seq data from extensive cell line datasets, scPDS improves accuracy and computational efficiency in scRNA‐seq analysis. It is demonstrated that scPDS outperforms state‐of‐the‐art methods in both time and memory consumption. When applied to breast cancer cells treated with bortezomib, scPDS showed that resistance increases initially but diminishes with prolonged exposure. The method also identifies drug‐sensitive populations in bortezomib‐resistant cells and predicts the efficacy of combination therapies, including docetaxel, gemcitabine, and irinotecan. Furthermore, scPDS successfully distinguishes between sensitive and resistant patients, predicting significantly different survival outcomes. In summary, scPDS offers a robust tool for predicting cellular responses, providing insights to optimize cancer treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Single-Cell AnalysisAntineoplastic AgentsNeoplasmsBreast NeoplasmsHumansDrug Resistance, NeoplasmCell Line, TumorDeep LearningBortezomibGemcitabineDeoxycytidineDocetaxelFemaleIrinotecanSequence Analysis, RNA

Stichwörter der Autor:innen

cancer drug responsepathway scoresingle cell RNA sequencingtransformer

Substanzen

Antineoplastic AgentsBortezomibGemcitabineDeoxycytidineDocetaxelIrinotecan

Autor:innen und Institutionen

  • Oujiang Laboratory, Zhejiang Lab for Regenerative Medicine, Vision and Brain Health, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325101, China.
  • School of Biomedical Engineering, Eye Hospital, Wenzhou Medical University, Wenzhou, Zhejiang, 325027, China.
  • School of Information and Communication Engineering, Hainan University, Haikou, 570228, China.
  • Hainan Institute of Real-World Data, Qionghai, Hainan, 571400, China.

ORCID-Profile: Yinghao Yao, Jianzhong Su

Förderung

  • National Key Research and Development Program of China
  • National Natural Science Foundation of China
  • Zhejiang Provincial Natural Science Foundation of China

Zitieren

APA

Yao, Y., Xu, Y., Zhang, Y., Gui, Y., Bai, Q., Zhu, Z., Peng, H., Zhou, Y., Chen, Z. J., Sun, J., & Su, J. (2025). Single Cell Inference of Cancer Drug Response Using Pathway‐Based Transformer Network. Small Methods. https://doi.org/10.1002/smtd.202400991

Vancouver

Yao Y, Xu Y, Zhang Y, Gui Y, Bai Q, Zhu Z, et al. Single Cell Inference of Cancer Drug Response Using Pathway‐Based Transformer Network. Small Methods. 2025. doi:10.1002/smtd.202400991

BibTeX
@article{Yao2025,
  author = {Yao, Yinghao and Xu, Yuandong and Zhang, Yaru and Gui, Yuanyuan and Bai, Qingshi and Zhu, Zhengbiao and Peng, Hui and Zhou, Yijun and Chen, Zhen Ji and Sun, Jie and Su, Jianzhong},
  title = {Single Cell Inference of Cancer Drug Response Using Pathway‐Based Transformer Network},
  journal = {Small Methods},
  year = {2025},
  doi = {10.1002/smtd.202400991}
}
Kostenlos starten →